CA2864084A1 - Timothy grass allergens and methods and uses for immune response modulation - Google Patents

Timothy grass allergens and methods and uses for immune response modulation Download PDF

Info

Publication number
CA2864084A1
CA2864084A1 CA2864084A CA2864084A CA2864084A1 CA 2864084 A1 CA2864084 A1 CA 2864084A1 CA 2864084 A CA2864084 A CA 2864084A CA 2864084 A CA2864084 A CA 2864084A CA 2864084 A1 CA2864084 A1 CA 2864084A1
Authority
CA
Canada
Prior art keywords
methods
timothy grass
immune response
response modulation
grass allergens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2864084A
Other languages
English (en)
French (fr)
Inventor
Alessandro Sette
Veronique SCHULTEN
Howard Grey
Bjoern Peters
Jason GREENBAUM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Jolla Institute For Allergy & Immunology
Original Assignee
La Jolla Institute For Allergy & Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Jolla Institute For Allergy & Immunology filed Critical La Jolla Institute For Allergy & Immunology
Publication of CA2864084A1 publication Critical patent/CA2864084A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
CA2864084A 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation Abandoned CA2864084A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US61/596,156 2012-02-07
US201261734886P 2012-12-07 2012-12-07
US61/734,886 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
CA2864084A1 true CA2864084A1 (en) 2013-08-15

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2864084A Abandoned CA2864084A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Country Status (13)

Country Link
US (1) US10428124B2 (enExample)
EP (1) EP2812026A4 (enExample)
JP (1) JP2015513527A (enExample)
KR (1) KR20140129124A (enExample)
CN (1) CN104203277A (enExample)
AU (1) AU2013216993C1 (enExample)
BR (1) BR112014019504A2 (enExample)
CA (1) CA2864084A1 (enExample)
EA (1) EA201491481A1 (enExample)
HK (1) HK1204929A1 (enExample)
IN (1) IN2014MN01513A (enExample)
MX (1) MX2014009285A (enExample)
WO (1) WO2013119863A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
EA201691028A1 (ru) 2013-11-20 2017-01-30 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
CN105848677B (zh) 2013-12-23 2020-01-31 爱尔开-阿贝优公司 在治疗尘螨过敏症中的肽组合及其用途
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
WO2016056596A1 (ja) * 2014-10-07 2016-04-14 日本電気株式会社 Ｈｓｐ７０由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
US10526388B2 (en) 2015-03-09 2020-01-07 Cytlimic Inc. Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
AU2016244570B2 (en) 2015-04-07 2020-08-27 Nec Corporation Medicine
CN109415741A (zh) * 2016-05-03 2019-03-01 Sqz生物技术公司 细胞内递送生物分子以诱导耐受性
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
KR20260017488A (ko) * 2017-04-28 2026-02-05 호유 가부시키가이샤 알레르기 항원 및 그 에피토프
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ES2384045T3 (es) * 2002-06-25 2012-06-28 Merck Patent Gmbh Secuencia de ADN y preparación recombinante del alérgeno del polen de gramíneas PHI P 4
US7731970B2 (en) 2002-08-19 2010-06-08 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
WO2006076423A2 (en) 2005-01-12 2006-07-20 Monsanto Technology, Llc Genes and uses for plant improvement
SI2244734T1 (sl) * 2008-02-01 2016-11-30 Murdoch Childrens Research Institute Postopek induciranja tolerance na alergen
EP2388268A1 (en) 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
BR112013009068A2 (pt) 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
CA2868469A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ／エスＡｌｋ−Ａｂｅｌｌｏ Ａ／Ｓ 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Also Published As

Publication number Publication date
CN104203277A (zh) 2014-12-10
IN2014MN01513A (enExample) 2015-09-11
BR112014019504A2 (pt) 2017-06-27
AU2013216993B2 (en) 2016-09-15
HK1204929A1 (en) 2015-12-11
EP2812026A4 (en) 2016-04-27
EA201491481A1 (ru) 2014-11-28
EP2812026A1 (en) 2014-12-17
AU2013216993C1 (en) 2017-01-19
JP2015513527A (ja) 2015-05-14
MX2014009285A (es) 2015-02-04
US20150023992A1 (en) 2015-01-22
US10428124B2 (en) 2019-10-01
AU2013216993A1 (en) 2014-08-21
KR20140129124A (ko) 2014-11-06
WO2013119863A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
HK1204929A1 (en) Timothy grass allergens and methods and uses for immune response modulation
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
WO2012024632A3 (en) Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
WO2014177459A3 (en) Fc-receptor binding modified asymmetric antibodies and methods of use
WO2011113019A3 (en) Ctla4 proteins and their uses
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
MX348071B (es) Variantes de fc.
SG11201505480SA (en) Amino acid and protein hydrolysate based formulas with a stable emulsion system
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
CA2835644C (en) Pre-fusion rsv f antigens
MX2019011952A (es) Proteina anti-garp y sus usos.
WO2014150877A3 (en) Anti-tau antibodies and methods of use
IL228649A0 (en) Immunogenic composition for immune system modulation and use thereof,method for treating and preventing diseases method for inducing cell regeneration and method for restoring immune response
BR112014033116A2 (pt) anticorpos para tau
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
WO2014204816A3 (en) Method for assessing protein identity and stability
HK1207654A1 (en) Modified antibody regions and uses thereof
WO2014184545A3 (en) Engineered fc variants
CA2866232A1 (en) Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition
WO2013084071A3 (en) Clostridium difficile toxin-based vaccine
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
HK1244460A1 (zh) 丝氨酸融合多肽和其使用方法
HK1246669A1 (zh) 人血清白蛋白低分子量组分在疾病治疗中的应用
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
WO2013095091A3 (en) Rsv g protein specific antibodies

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190207